Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant disease with poor prognosis, and most cases were already considered unresectable at the time of presentation. Conversion therapy, as an emerging treatment, is designed to provide patients with initially unresectable hepatocellular carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weiwei, Pei, Yinxuan, Wang, Zixiang, Liu, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377519/
https://www.ncbi.nlm.nih.gov/pubmed/35978834
http://dx.doi.org/10.3389/fonc.2022.930868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377519/
https://www.ncbi.nlm.nih.gov/pubmed/35978834
http://dx.doi.org/10.3389/fonc.2022.930868

Ejemplares similares